Prevalence of Metabolic Syndrome in Women with Polycystic Ovary Syndrome Attending an Infertility Clinic in a Tertiary Care Hospital in South India

Overview

Journal J Hum Reprod Sci

Date 2012 Aug 8

PMID 22870011

Citations 21

Authors

Kavita Mandrelle

Mohan S Kamath

Dian J Bondu

Achamma Chandy

Tk Aleyamma

Korula George

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (PCOS).

Setting: Infertility clinic in a tertiary care hospital.

Study Design: A prospective cross-sectional study.

Materials And Methods: All the women attending the infertility clinic categorized as polycystic ovary syndrome according to Rotterdam criteria (2003) during the study period were included in the study. The women with PCOS underwent screening for metabolic syndrome as defined by the modified American Heart Association/National Heart Lung Blood Institute (AHA/NHLBI) modified ATP 111 (2005) definition. A multivariate logistic regression analysis was applied and significant predictors identified for the prediction of metabolic syndrome.

Results: The overall prevalence of metabolic syndrome according to the modified AHA/NHLBI ATP III (2005) criteria was 37.5%. A total of 5.8 % cases were detected to have diabetes mellitus, 8.3% had impaired fasting glucose, and 11.7 % had an impaired glucose test. Dyslipidemia was present in 93.3% cases of PCOS. Among all the risk factors, age and waist hip ratio ≥0.85 were strongly associated with the presence of metabolic syndrome.

Conclusion: Infertile women with PCOS, particularly those with age ≥25 years or with central obesity (a waist hip ratio of ≥0.85), are at a higher risk of developing metabolic syndrome and should be offered screening tests.

Citing Articles

The association between the follicular distribution pattern of polycystic ovaries and metabolic syndrome development in patients with polycystic ovary syndrome a prospective cohort study.

Pourkhani Z, Jahanian Sadatmahalleh S, Moini A, Nasiri M Sci Rep. 2025; 15(1):5284.

PMID: 39939752 PMC: 11822200. DOI: 10.1038/s41598-025-89745-z.

Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity.

Baba T Reprod Med Biol. 2025; 24(1):e12630.

PMID: 39845478 PMC: 11751892. DOI: 10.1002/rmb2.12630.

Practise Updates: Diagnosis and Management of Idiopathic Hirsutism.

Khare V, Sinha B, Sengupta N, Chatterjee S, Maji D, Majumder A Indian J Endocrinol Metab. 2024; 28(3):239-249.

PMID: 39086564 PMC: 11288517. DOI: 10.4103/ijem.ijem_2_24.

An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India.

Patil A, Vaidya R, Begum S, Chauhan S, Mukherjee S, Kokate P Indian J Med Res. 2023; 156(3):449-458.

PMID: 36588359 PMC: 10101363. DOI: 10.4103/ijmr.IJMR_2497_19.

A comparison of the effects of cinnamon, ginger, and metformin consumption on metabolic health, anthropometric indices, and sexual hormone levels in women with poly cystic ovary syndrome: A randomized double-blinded placebo-controlled clinical trial.

Dastgheib M, Barati-Boldaji R, Bahrampour N, Taheri R, Borghei M, Amooee S Front Nutr. 2022; 9:1071515.

PMID: 36523331 PMC: 9745082. DOI: 10.3389/fnut.2022.1071515.

References

Goverde A, van Koert A, Eijkemans M, Knauff E, Westerveld H, Fauser B . Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod. 2008; 24(3):710-7. DOI: 10.1093/humrep/den433. View

Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia D . Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005; 106(1):131-7. DOI: 10.1097/01.AOG.0000167408.30893.6b. View

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

Korhonen S, Hippelainen M, Niskanen L, Vanhala M, Saarikoski S . Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol. 2001; 184(3):289-96. DOI: 10.1067/mob.2001.109596. View

DeFronzo R, Ferrannini E . Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14(3):173-94. DOI: 10.2337/diacare.14.3.173. View

Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K . Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2007; 115(2):130-5. DOI: 10.1055/s-2007-967093. View

Shroff R, Syrop C, Davis W, Van Voorhis B, Dokras A . Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril. 2007; 88(5):1389-95. DOI: 10.1016/j.fertnstert.2007.01.032. View

Bhattacharya S . Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria. J Obstet Gynaecol Res. 2008; 34(1):62-6. DOI: 10.1111/j.1447-0756.2007.00685.x. View

Cheung L, Ma R, Lam P, Lok I, Haines C, So W . Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod. 2008; 23(6):1431-8. DOI: 10.1093/humrep/den090. View

10.

Legro R . Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocr Rev. 2003; 24(3):302-12. DOI: 10.1210/er.2003-0004. View

11.

Lepor N, Vogel R . Summary of the third report of the National Cholesterol Education Program Adult Treatment Panel III. Rev Cardiovasc Med. 2002; 2(3):160-5. View

12.

Janssen I, Katzmarzyk P, Ross R . Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004; 79(3):379-84. DOI: 10.1093/ajcn/79.3.379. View

13.

Franks S . Polycystic ovary syndrome. N Engl J Med. 1995; 333(13):853-61. DOI: 10.1056/NEJM199509283331307. View

14.

Soares E, Azevedo G, Gadelha R, Lemos T, Maranhao T . Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2007; 89(3):649-55. DOI: 10.1016/j.fertnstert.2007.03.081. View

15.

Barber T, McCarthy M, Wass J, Franks S . Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2006; 65(2):137-45. DOI: 10.1111/j.1365-2265.2006.02587.x. View

16.

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735-52. DOI: 10.1161/CIRCULATIONAHA.105.169404. View

17.

Eckel R, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2005; 365(9468):1415-28. DOI: 10.1016/S0140-6736(05)66378-7. View

18.

Dunaif A . Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997; 18(6):774-800. DOI: 10.1210/edrv.18.6.0318. View

19.

Essah P, Nestler J . Metabolic syndrome in women with polycystic ovary syndrome. Fertil Steril. 2006; 86 Suppl 1:S18-9. DOI: 10.1016/j.fertnstert.2006.04.013. View

20.

Vrbikova J, Vondra K, Cibula D, Dvorakova K, Stanicka S, Sramkova D . Metabolic syndrome in young Czech women with polycystic ovary syndrome. Hum Reprod. 2005; 20(12):3328-32. DOI: 10.1093/humrep/dei221. View